BioCapture Copenhagen A/S: Financial statements 2023
CVR: 43368575
Source: annual report 2023, Danish Business Authority
01/07/2022 – 30/06/2023
BioCapture Copenhagen A/S (CVR 43368575) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 0 and a net result of DKK 3,667. Equity in the 2023 report amounted to DKK 1,003,667. The solvency ratio was 99.9%.
- Gross Profit
- DKK 0
- Profit/Loss
- DKK 3,667
- Equity
- DKK 1,003,667
- Total Assets
- DKK 1,004,642
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of November 20, 2023, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of BioCapture Copenhagen A/S.
About BioCapture Copenhagen A/S
BioCapture Copenhagen A/S is a Danish company of the type Aktieselskab based in København S, founded in 2022. The company is registered under the industry Deponering eller permanent oplagring. The company was previously named HOFOR DSS SPV A/S and Implement International A/S. The management consists of Gorm Kildahl Elikofer. The board consists of Henrik Plougmann Olsen (chair), Charlotte Alsing Søndergren, Hanne Hansen and Mads Grønvall. The company is owned by HOFOR CC HOLDING A/S. According to the 2024 annual report, the company had an average of 1 employee. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK -4,141 compared with DKK 3,667 the year before. Equity in the 2024 report amounted to DKK 999,526.
